Financial Contrast: Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF)

Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends.

Profitability

This table compares Sonic Healthcare and Amplifon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sonic Healthcare	N/A	N/A	N/A
Amplifon	4.74%	14.28%	3.89%

Analyst Recommendations

This is a summary of current recommendations and price targets for Sonic Healthcare and Amplifon, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonic Healthcare	1	0	1	0	2.00
Amplifon	0	0	2	0	3.00

Sonic Healthcare presently has a consensus target price of $30.15, indicating a potential upside of 78.51%. Given Sonic Healthcare’s higher probable upside, analysts plainly believe Sonic Healthcare is more favorable than Amplifon.

Risk & Volatility

Sonic Healthcare has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Amplifon has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500.

Valuation and Earnings

This table compares Sonic Healthcare and Amplifon”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonic Healthcare	$6.25 billion	1.34	$332.61 million	N/A	N/A
Amplifon	$2.61 billion	1.35	$157.31 million	$0.56	27.97

Sonic Healthcare has higher revenue and earnings than Amplifon.

Insider & Institutional Ownership

0.0% of Sonic Healthcare shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Amplifon beats Sonic Healthcare on 6 of the 11 factors compared between the two stocks.

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

About Amplifon

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.